SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-036218
Filing Date
2015-05-08
Accepted
2015-05-08 15:46:44
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a15-7167_110q.htm 10-Q 896642
2 EX-10.64 a15-7167_1ex10d64.htm EX-10.64 15341
3 EX-31.1 a15-7167_1ex31d1.htm EX-31.1 11924
4 EX-31.2 a15-7167_1ex31d2.htm EX-31.2 12408
5 EX-32 a15-7167_1ex32.htm EX-32 9992
  Complete submission text file 0001104659-15-036218.txt   5878212

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT thrx-20150331.xml EX-101.INS 880729
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20150331.xsd EX-101.SCH 44552
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20150331_cal.xml EX-101.CAL 47608
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20150331_lab.xml EX-101.LAB 400075
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20150331_pre.xml EX-101.PRE 268149
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20150331_def.xml EX-101.DEF 142493
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 15846492
SIC: 2834 Pharmaceutical Preparations